Summary
This prediction ended on 01.11.22 with a price of €16.86. The SELL prediction by BiotechBee finished with a performance of 11.64%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
GSK plc | 2.946% | 2.946% | 23.688% |
iShares Core DAX® | 1.883% | 5.122% | 21.667% |
iShares Nasdaq 100 | 0.125% | 2.574% | 45.951% |
iShares Nikkei 225® | -0.201% | 4.341% | 28.806% |
iShares S&P 500 | 0.728% | 4.141% | 34.630% |
According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread GlaxoSmithKline plc diskutieren
Sell mit Kursziel 10,0
In the thread Trading GlaxoSmithKline plc
Sell beendet